Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Cancer Immunology, Immunotherapy : CII|December 25, 2014
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Dan P Zandberg, Sandra Rollins, Olga Goloubeva, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung CancerMelissa A L Vyfhuis, Whitney M Burrows, Neha Bhooshan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Oral Oncology|February 28, 2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522Musaddiq J Awan, Haley Gittleman, Jill Barnholtz-Sloan, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
JAMA Network Open|April 21, 2023
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical TrialsChristopher L Hallemeier, Jennifer Moughan, Michael G Haddock, et al.
Pageof 9